Image-guided therapy of myocardial disease: composition, manufacturing and applications
First Claim
Patent Images
1. An imaging agent comprising a beta-adrenergic receptor ligand conjugated to a terminal nitrogen of a polyethylene amine derived chelator.
1 Assignment
0 Petitions
Accused Products
Abstract
Compositions and methods for imaging and for chemotherapy and radiotherapy are disclosed. More particularly, the invention concerns agents comprising a targeting moeity comprising a beta-adrenergic receptor targeting compound conjugated or embedded with ethylenediamine. The present invention also concerns methods of application of such agents for imaging and treatment of cardiovascular diseases, and kits for preparing a radiolabeled therapeutic or diagnostic agent.
40 Citations
17 Claims
- 1. An imaging agent comprising a beta-adrenergic receptor ligand conjugated to a terminal nitrogen of a polyethylene amine derived chelator.
Specification